Pathogenetic importance of cytokines in acuterespiratory diseases in children
Abstract
The literature review shows the important role of the cytokine system in complex protective reactions inacute respiratory pathologies in children. It is known that IL-1β, IL-6, IL-18 were multifunctional pro-inflammatory cytokines that, playing an important role in the differentiation and activation of cells of the immune system, influenced immunopathogenesis, the clinical course of the disease, and the activity of the inflammatory process.The study of the features of the cytokine system allows us to predict the clinical course of acute respiratory infections in children, to improve therapeutic and preventive measures
References
George V. G., Nikolaos G. P.Viral Upper Respiratory Tract Infections // Viral Infections in Children, Volume II Robin J. Green. — Cham: Springer International Publishing, -2017. -P. 1-25.
Баранов А.А., Баранова Л.С., Лобзин Ю.В., Таточенко В.К., Усков А.Н., Куличенко Т.В., Бакрадзе М.Д., Вишнёва Е.А., Селимзянова Л.Р., Полякова А.С., Артёмова И.В., Промыслова Е.А. Острая респираторная вирусная инфекция у детей: современные подходы к диагностике и лечению// Вопросы современной педиатрии. -2017. -№14(2).-C.100–108
Пикуза О.И.,Ризваерва Ф.Ф.,Генералова У.В.,Кравцова О.А. Полиморфизм генов про- и противовоспалителъных цитокинов и острый бронхит у детей //Российский вестник перинатологии и педиатрии.-2017.-№ 62(5).-C.136-1 .
Труишина Е.Ю., Баранова Н.И., Молотилов Б.А. Ролъ цитокинов иммунопатогенезе хронической обструктивной болезни легких // Медицинска иммунология.- 2019.-№ 21(1).-C.89-98.
Зинин Е.П., Царенко С.В., Логунов Д.Ю., Тухватулин А.И., Бабаянц А.В., Аврамов А.А.. Роль провоспалительных и противовоспалительных цитокинов при бактериальной пневмонии //Вестник интенсивной терапии им. А.И. Салтанова.- 2021.-№1.-C.77–89
Симбирцев А. С., Янов Ю. К., Варюшина Е. А., Тырнова Е. В. Роль цитокинов при лечении острых и хронических заболеваний верхних дыхательных путей //Российская оториноларингология. -2008.-№ 37 (6).-C. 200–05.
Васильева А., Жахов B., Трофимов A.B. и др. // Цитокины и воспаление. -2003. - Т.2, № 2. - С.51-57.
Насонов Е.Л. Роль интерлейкина 1 в развитии заболеваний человека// Научно-практическая ревматология. -2018.-№56(4).-C.19-27.
Dinarello C.A. Overview of the IL-1 family in innate inflammation and acquired immunity// Immunol Rev.-2018.-Vol.281(1).-C. 8-27
Khazim K, Azulay EE, Kristal B, Cohen I. Interleukin 1 gene polymorphism and susceptibility to disease// Immunol Rev. -2018.-Vol. 281 (1).-C. 40
Wonnenberg B, Bischoff M, Beisswenger C, Dinh T, Bals R, Singh B, Tschernig T.The role of IL-1β in Pseudomonas aeruginosa in lung infection//Cell Tissue Res.- 2016.-Vol.364(2).-C.225-9
Borthwick L.A. The IL1 cytokine family and its role in inflammation and fibro sis in the lung//Semin Immunopathol. -2016.-Vol. (4).-P.517–34
Симбирцев А.С. Биология семейства интерлейкина-1 человека // Иммунология. -1998. - №3. - С. 9-17
Choy E.H.S., Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis // The New England Journal of Medicine. - 2001. -Vol. 344, №12. -P. 907-916.
Zhao L., Wang L., Zhang X., et al. Reduced levels of interleukin 1 receptor antagonist act as a marker for pneumonia in the elderly// Mol Med Rep. -2014.-Vol. 10(2).-P. 959–964.
Hellyer T.P., Anderson N.H., Parker J., et al. Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial//Trials. -2016.-Vol. 17(1).-P.318
КазаковаА. В., УвароваЕ. В., ЛимареваЛ. В., ЛиневаО. И., СветловаГ. Н.,Трупакова А. А. Оcобенности полиморфизма генов провоспалительных цитокинов у девочек, предрасположенных к частым респираторным заболеваниям //Вестник РГМУ – 2019.-№6.-C.61-66
Netea M.G., Veerdonk F.L., Meer J.W., et al. Inflammasome-independent regulation of IL-1-family cytokines// Ann Rev Immunol. -2015.-Vol.33.-P.49-77
Dayer J.M., Oliviero F., Punzi L. A Brief History of IL-1 and IL-1 Ra in Rheumatology// Front Pharmacol. -2017.-P 8:
Насонов Е.Л., Елисеев М.С. Роль интерлейкина 1 в развитии заболеваний человека// Научно-практическая ревматология. -2016.-№.54(1).-C.60-77.
Cavalli G., Dinarello C.A. Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies// Rheumatology.-2015.-Vol.54.-P.2134-44.
Afonina I.S., Mü ller C., Martin S.J., Beyaert R. Proteolytic processing of Interleukin-1 family cytokines: variations on a common theme// Immunity. -2015.-Vol.42.-P.991-1004.
Gabay G., Lamacchia C., Palme G. IL-1 pathways in inflammation and human diseases// Nat Rev Rheumatol. -2014.-Vol.6.-P.232-41.
Roerink M.A., Van der Schaaf M.E., Dinarello C.A., Knoop H., Van der Meer J.W.M. Interleukin-1 as a mediator of fatigue in disease: a narrative review// Neuroinflammation. -2017.-Vol.14.-P.16-36.
Patankar Y.R. Differential ASC requirements reveal a key role for neu trophils and a noncanonical İL-1 response to Pseudomonas aeruginosa// Am J Physiol Lung Cell Mol Physiol. -2015.-Vol.309(8).-P.902-13
Toshio T., Masashi N., Tadamitsu K.L-6 in Inflammation, Immunity, and Disease//Cold Spring Harb Perspect Biol. -2014.-Vol. 6(10)
Tanaka T., Narazaki M., Kishimoto T. IL-6 in inflammation, immunity, and disease (неопр.) // Cold Spring Harb Perspect Biol. - 2014. -Vol. 6, № 10.
Mauer J., Denson J. L., and Bruning J. C. (2015). Versatile functions for IL-6 in metabolism and cancer// Trends Immunol. -2015.-Vol.36.-P.92–101.
Yang R., Masters A. R., Fortner K. A., Champagne D. P., Yanguas-Casas N., Silberger D. J., et al. (2016). IL-6 promotes the differentiation of a subset of naive CD8+ T cells into IL-21-producing B helper CD8+ T cells// Exp. Med. -2016.-Vol.213.-P. 2281–2291.
Zheng J., Shi Y., Xiong L., Zhang W., Li Y., Gibson P. G., et al. (2017). The expression of IL-6, TNF-alpha, and MCP-1 in respiratory viral infection in acute exacerbations of chronic obstructive pulmonary disease// Immunol.Res. -2017.-Vol.85.-P.392-94.
Aronson D., Roterman I., Yigla M. et al .Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects// Am J Respir Crit Care Med.- 2006.-Vol.174.-P.626–32.
Dienz O. and Rincon M. (2009). The effects of IL-6 on CD4 T cell responses// Clin.Immunol. -2009.-Vol.130.-P.27–33.
Carbone G, Wilson A, Diehl SA, Bunn J, Cooper SM, Rincon M 2013. Interleukin-6 receptor blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis// Int J Biol Sci.-2013.-Vol.9.-P. 279–288
Wu W., Dietze K. K., Gibbert K., Lang K. S., Trilling M., Yan H., et al. TLR ligand induced IL-6 counter-regulates the anti-viral CD8(+) T cell response during an acute retrovirus infection// Sci. Rep.-2015.-Vol. 5.-P.10501.
Li T.,Zhang J.,Yang Y., et al. The potential role of İL-6 in monitoring severe case of coronovirus disease //Natl Sci Rev. -2020.-Vol. 7(6).-P. 1003–1011.
Ruan Q., Yang K., Wang W., Jiang L., Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China // Intensive Care Med. -2020.-Vol.46(5).-P.846-8
Sun X., Wan T., Cai D., HZ Chen J., Liao H., et al. Cytokine Storm Intervention in The Early Stages of COVID-19 Pneumonia// Cytokine Growth Factor Rev.-2020.-Vol. 3.-P. -42. . Velazquez S. L, Verdugo R. A, Rodriguez LL and Borca MV. The Role of Interleukin 6 During Viral Infections// Front. Microbiol.-2019.-Vol.10.-P.1057.
. Rincon M., Irvin C.G.Role of IL-6 in asthma and other inflammatory pulmonary diseases//Int J Biol Sci. -2012.-Vol.8(9).-P.1281-90.
Poynter M.E., Irvin C.G. İnterleukin-6 as a biomarker for asthma: hype or is there something else?// Eur Respir.-2016.-Vol.48(4).-P.979-981
Mehta P.,McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: consider cytokine storm syndromes and immunosuppression// Lancet.-2020.-Vol. 395.-P. 1033-1034,
Grover V., Pantelidis P., Soni N., et al. A biomarker panel (Bioscore) incorporating monocytic surface and soluble TREM-1 has high discriminative value for ventilator-associated pneumonia: a prospective observational study// PLoS One. -2014.-Vol. 9(10).
Zobel K., Martus P., Pletz M.W. et al. Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network capnetz// BMC Pulm Med.-2012.-Vol. 12.-P. 6
Bacci M.R., Leme R.C., Zing N.P. et al. IL-6 and TNF-alpha serum levels are associated with early death in community-acquired pneumonia patients// Med Biol Res.- 2015.-Vol. 48(5).-P.427–432.
Gilles K. Interleukin-18: Biological properties and role in disease pathogenesis//Immunol Rev. -2018.-Vol.281(1).-P.1 -153
Keywords
immune system
cytokines tənəffüs yolları
immun sistem
sitokinlər дыхательные пути
иммуная система
цитокины
Most read articles by the same author(s)
- Hasanov A.Q., Huseynova İ. E., The role of cytokines in diseases of the respiratory trаct in children. , Azerbaijan Journal of Perinatology and Pediatrics: Vol. 7 No. 1 (2021): JOURNAL OF AZERBAIJAN PERINATOLOGY AND PEDIATRICS